https://www.prwcc.org/jobs-1/mcnerney-ko%2C-moskop-a%2C-winestone-le%2C-baggott-c%2C-talano-ja%2C-schiff-d%2C-rossoff-j%2C-modi-a%2C-verneris-mr%2C-laetsch-tw%2C-schultz-l.-practice-preferences-for-consolidative-hematopoietic-stem-cell-transplantation-following-tisagenlecleucel-in-children-and-young-adults-with-b-cell-acute-lymphoblastic-leukemia.-transplant-cell-ther.-2024-jan%3B30(1)%3A75.e1-75.e11.-doi%3A-10.1016%2Fj.jtct.2023.10.004.-epub-2023-oct-8.-pmid%3A-37816472. 2025-03-06 https://www.prwcc.org/jobs-1/jonathan-d.-bender%2C-sudarshawn-damodharan%2C-christian-m.-capitini%2C-amy-moskop%2C-keri-toner%2C-anant-vatsayan%2C-julie-an-talano%2C-christina-baggott%2C-deborah-schiff%2C-emmanuel-katsanis%2C-arunkumar-j.-modi%2C-troy-c.-quigg%2C-sunil-s.-raikar%2C-liora-m.-schultz%2C-lauren-pommert%3B-real-world-use-of-tisagenlecleucel-in-children-and-young-adults-with-relapsed-or-refractory-b-cell-lymphomas.-blood-adv-2024%3B-8-(15)%3A-4164%E2%80%934168.-doi%3A-https%3A%2F%2Fdoi.org%2F10.1182%2Fbloodadvances.2024012928 2025-03-06 https://www.prwcc.org/jobs-1/kevin-mcnerney-et-al.%2C-high-disease-burden-and-severe-neutropenia-predict-hlh-toxicities-in-patients-with-b-acute-lymphoblastic-leukemia-(b-all)-treated-with-tisagenlecleucel-in-the-prwcc%2C-astct-2023%2C-abstract 2025-03-06 https://www.prwcc.org/jobs-1/kevin-mcnerney-et-al.%2C-clinical-practice-patterns-and-factors-driving-usage-of-consolidative-hsct-post-tisagenlecleucel%2C-astct-2023%2C-abstract 2025-03-06 https://www.prwcc.org/jobs-1/maya-eylon-et-al.%2C-mediport-use-as-an-acceptable-standard-for-car-t-cell-infusion%2C-astct-2023%2C-abstract 2025-03-06 https://www.prwcc.org/jobs-1/mcnerney-ko%2C-lim-ss%2C-vatsayan-a%2C-dreyzin-a%2C-baggott-c%2C-prabhu-s%2C-pacenta-h%2C-philips-c%2C-rossoff-j%2C-stefanski-h%2C-talano-ja%2C-moskop-a%2C-margossian-s%2C-verneris-m%2C-myers-d%2C-karras-n%2C-brown-p%2C-qayed-m%2C-hermiston-m%2C-satwani-p%2C-krupski-c%2C-keating-a%2C-wilcox-r%2C-rabik-c%2C-baumeister-s%2C-fabrizio-v%2C-chinnabhandar-v%2C-goksenin-y%2C-curran-k%2C-mackall-cl%2C-laetsch-t%2C-schultz-l.-chimeric-antigen-receptor-(car)-associated-hemophagocytic-lymphohistiocytosis-(hlh)-with-use-of-commercial-tisagenlecleucel-in-the-pediatric-real-world-car-consortium-(prwcc)%3A-risk-factors-and-outcomes%2C-astct-2022%2C-late-breaking-abstract 2025-03-06 https://www.prwcc.org/jobs-1/pacenta-h%2C-schultz-l%2C-baggot-c%2C-shah-n%2C-prabhu-s%2C-phillips-c%2C-rossoff-j%2C-stefanski-h%2C-talano-ja%2C-moskop-a%2C-margossian-s%2C-verneris-m%2C-myers-gd%2C-karras-na%2C-brown-pa%2C-qayed-m%2C-hermiston-m%2C-satwani-p%2C-krupski-c%2C-keating-ak%2C-wilcox-r%2C-rabik-c%2C-fabrizio-v%2C-rouce-r%2C-chinnabhandar-v%2C-kunicki-m%2C-barsan-v%2C-goksenin-y%2C-curran-k%2C-mackall-cl%2C-laetsch-t.-real-world-treatment-of-pediatric-patients-with-down-syndrome-and-relapsed%2Frefractory-b-all-treated-with-tisagenlecleucel%2C-siop-2021%2C-oral-abstract 2025-03-06 https://www.prwcc.org/jobs-1/barsan-v%2C-baggot-c%2C-prabhu-s%2C-pacenta-h%2C-phillips-c%2C-rossoff-j%2C-stefanski-h%2C-talano-ja%2C-moskop-a%2C-margossian-s%2C-verneris-m%2C-myers-gd%2C-karras-na%2C-brown-pa%2C-qayed-m%2C-hermiston-m%2C-satwani-p%2C-krupski-c%2C-keating-a%2C-wilcox-r%2C-rabik-c%2C-fabrizio-v%2C-chinnabhandar-v%2C-kunicki-m%2C-gokesnin-y%2C-curran-k%2C-mackall-cl%2C-laetsch-t%2C-schultz-l.-real-world-indications-for-chimeric-antigen-receptor-t-cell-therapy-and-referral-patterns-in-pediatric-patients-with-relapsed-of-high-risk-leukemia%2C-siop%2C-abstract 2025-03-06 https://www.prwcc.org/jobs-1/schultz-l%2C-baggott-c%2C-prabhu-s%2C-pacenta-h%2C-phillips-c%2C-rossoff-j%2C-stafanski-h%2C-talano-ja%2C-moskop-a%2C-margossian-sp%2C-verneris-m%2C-myers-gd%2C-karras-na%2C-brown-pa%2C-qayed-m%2C-hermiston-m%2C-satwani-p%2C-krupski-c%2C-keating-a%2C-wilcox-r%2C-rabik-c%2C-fabrizio-v%2C-rouce-r%2C-chinnabhandar-v%2C-kunicki-m%2C-goksenin-y%2C-curran-kj%2C-mackall-cl%2C-laetsch-tw.-predictive-value-of-next-generation-sequencing-(ngs)-following-tisagenlecleucel-in-pediatric-and-young-adult-b-cell-acute-lymphoblastic-leukemia%2C-astct-2021%2C-abstract 2025-03-06 https://www.prwcc.org/jobs-1/moskop-a%2C-talano-ja%2C-verneris-m%2C-baggott-c%2C-prabhu-s%2C-pacenta-h%2C-phillips-c%2C-rossoff-j%2C-stafanski-h%2C-margossian-sp%2C-myers-gd%2C-karras-na%2C-brown-pa%2C-qayed-m%2C-hermiston-m%2C-satwani-p%2C-krupski-c%2C-keating-a%2C-wilcox-r%2C-rabik-c%2C-fabrizio-v%2C-rouce-r%2C-chinnabhandar-v%2C-kunicki-m%2C-goksenin-y%2C-curran-kj%2C-mackall-cl%2C-laetsch-tw%2C-schultz-l.-immune-reconstitution-and-infections-in-the-real-world-use-of-tisagenlecleucel-in-pediatric-and-young-adult-acute-lymphoblastic-leukemia%2C-astct-2021%2C-abstract 2025-03-07 https://www.prwcc.org/jobs-1/fabrizio-va%2C-phillips-cl%2C-baggott-c%2C-prabhu-s%2C-pacenta-h%2C-rossoff-j%2C-stafanski-h%2C-talano-ja%2C-moskop-a%2C-margossian-sp%2C-verneris-m%2C-myers-gd%2C-karras-na%2C-brown-pa%2C-qayed-m%2C-hermiston-m%2C-satwani-p%2C-krupski-c%2C-keating-a%2C-wilcox-r%2C-rabik-c%2C-rouce-r%2C-chinnabhandar-v%2C-kunicki-m%2C-goksenin-y%2C-curran-kj%2C-mackall-cl%2C-laetsch-tw%2C-schultz-l%2C-real-world-treatment-of-pediatric-patients-with-relapsed%2Frefractory-cns-b-cell-leukemia-using-tisagenlecleucel%2C-astct-2021%2C-abstract 2025-03-06 https://www.prwcc.org/jobs-1/stefanski-h%2C-eaton-a%2C-baggott-c%2C-prabhu-s%2C-pacenta-h%2C-phillips-c%2C-rossoff-j%2C-talano-ja%2C-moskop-a%2C-margossian-sp%2C-verneris-m%2C-myers-gd%2C-karras-na%2C-brown-pa%2C-qayed-m%2C-hermiston-m%2C-satwani-p%2C-krupski-c%2C-keating-a%2C-wilcox-r%2C-rabik-c%2C-fabrizio-v%2C-rouce-r%2C-chinnabhandar-v%2C-kunicki-m%2C-goksenin-y%2C-curran-kj%2C-mackall-cl%2C-laetsch-tw%2C-schultz-l%2C-post-relapse-outcomes-following-tisagenlecleucel%3A-poor-survival%2C-despite-current-salvage-therapies%3A--results-from-the-pediatric-real-world-car-consortium-(prwcc)%2C-astct-2021%2C-oral-abstract 2025-03-06 https://www.prwcc.org/jobs-1/moskop-a%2C-breese-e%2C-gest-e%2C-pommert-l%2C-baggott-c%2C-prabhu-s%2C-pacenta-h%2C-phillips-c%2C-rossoff-j%2C-stafanski-h%2C-talano-ja%2C-moskop-a%2C-margossian-sp%2C-verneris-m%2C-myers-gd%2C-karras-na%2C-brown-pa%2C-qayed-m%2C-hermiston-m%2C-satwani-p%2C-krupski-c%2C-keating-a%2C-wilcox-r%2C-rabik-c%2C-fabrizio-v%2C-rouce-r%2C-chinnabhandar-v%2C-kunicki-m%2C-goksenin-y%2C-curran-kj%2C-mackall-cl%2C-laetsch-tw%2C-schultz-l%2C-real-world-use-of-tisagenlecleucel-in-infant-acute-lymphoblastic-leukemia%2C-astct-2021%2C-oral-abstract 2025-03-06 https://www.prwcc.org/jobs-1/stefanski-h%2C-eaton-a%2C-baggott-c%2C-prabhu-s%2C-pacenta-h%2C-phillips-c%2C-rossoff-j%2C-talano-ja%2C-moskop-a%2C-margossian-sp%2C-verneris-m%2C-myers-gd%2C-karras-na%2C-brown-pa%2C-qayed-m%2C-hermiston-m%2C-satwani-p%2C-krupski-c%2C-keating-a%2C-wilcox-r%2C-rabik-c%2C-fabrizio-v%2C-rouce-r%2C-chinnabhandar-v%2C-kunicki-m%2C-goksenin-y%2C-curran-kj%2C-mackall-cl%2C-laetsch-tw%2C-schultz-l%2C-impact-of-tisagenlecleucel-dose-on-relapse%3A-results-from-the-pediatric-real-world-consortium%2C-astct-2021%2C-late-breaking-abstract 2025-03-07 https://www.prwcc.org/jobs-1/baggott-c%2C-prabhu-s%2C-pacenta-h%2C-phillips-c%2C-rossoff-j%2C-stafanski-h%2C-talano-ja%2C-moskop-a%2C-margossian-sp%2C-verneris-m%2C-myers-gd%2C-karras-na%2C-brown-pa%2C-qayed-m%2C-hermiston-m%2C-satwani-p%2C-krupski-c%2C-keating-a%2C-wilcox-r%2C-rabik-c%2C-fabrizio-v%2C-rouce-r%2C-chinnabhandar-v%2C-kunicki-m%2C-goksenin-y%2C-mackall-cl%2C-bhatia-s%2C-curran-kj%2C-laetsch-tw%2C-liora-schultz%2C-inferior-outcomes-among-black-childhood-acute-lymphoblastic-leukemia-patients-following-tisagenlecleucel-astct-2021%2C-late-breaking-abstract 2025-03-07 https://www.prwcc.org/jobs-1/curran-kj%2C-fabrizio-v%2C-baggott-c%2C-prabhu-s%2C-pacenta-h%2C-phillips-c%2C-rossoff-j%2C-stafanski-h%2C-talano-ja%2C-moskop-a%2C-margossian-sp%2C-verneris-m%2C-myers-gd%2C-karras-na%2C-brown-pa%2C-qayed-m%2C-hermiston-m%2C-satwani-p%2C-krupski-c%2C-keating-a%2C-wilcox-r%2C-rabik-c%2C-rouce-r%2C-chinnabhandar-v%2C-kunicki-m%2C-goksenin-y%2C-mackall-cl%2C-laetsch-tw%2C-schultz-l%2C-fludarabine-pharmacokinetics-on-outcomes-following-tisagenlecleucel-in-pediatric-acute-lymphoblastic-leukemia%2C-istct-2021%2C--oral-abstract 2025-03-06 https://www.prwcc.org/jobs-1/schultz-l%2C-baggott-c%2C-prabhu-s%2C-pacenta-h%2C-phillips-c%2C-rossoff-j%2C-stafanski-h%2C-talano-ja%2C-moskop-a%2C-margossian-sp%2C-verneris-m%2C-myers-gd%2C-karras-na%2C-brown-pa%2C-qayed-m%2C-hermiston-m%2C-satwani-p%2C-krupski-c%2C-keating-a%2C-wilcox-r%2C-rabik-c%2C-fabrizio-v%2C-rouce-r%2C-chinnabhandar-v%2C-kunicki-m%2C-goksenin-y%2C-curran-kj%2C-mackall-cl%2C-laetsch-tw.-disease-burden-impacts-outcomes-in-pediatric-and-young-adult-b-cell-lymphoblastic-leukemia-after-commercial-tisagenlecleucel%3B-results-from-the-pediatric-real-world-car-consortium-(prwcc)%2C-ash-2020%2C-oral-abstract 2025-03-06 https://www.prwcc.org/jobs-1/rossoff-j%2C-baggott-c%2C-prabhu-s%2C-pacenta-h%2C-phillips-c%2C-stafanski-h%2C-talano-ja%2C-moskop-a%2C-margossian-sp%2C-verneris-m%2C-myers-gd%2C-karras-na%2C-brown-pa%2C-qayed-m%2C-hermiston-m%2C-satwani-p%2C-krupski-c%2C-keating-a%2C-wilcox-r%2C-rabik-c%2C-fabrizio-v%2C-rouce-r%2C-chinnabhandar-v%2C-kunicki-m%2C-goksenin-y%2C-curran-kj%2C-mackall-cl%2C-laetsch-tw%2C-schultz-l.-real-world-treatment-of-pediatric-patients-with-relapsed%2Frefractory-b-cell-acute-lymphoblastic-leukemia-using-tisagenlecleucel-that-is-out-of-specification-for-commercial-release%2C-ash-2020%2C-abstract 2025-03-06 https://www.prwcc.org/jobs-1/anthony-ross-et-al.%2C-obesity-associates-with-inferior-outcomes-and-toxicity-in-pediatric-and-young-adult-patient-with-relapsed%2Frefractory-b-cell-acute-lymphoblastic-leukemia-treated-with-commercially-manufactured-tisagenlecleucel%2C-ash-2020%2C-abstract 2025-03-06 https://www.prwcc.org/jobs-1/vanessa-fabrizio-et-al.%2C-peripheral-blast-count-at-apheresis-acts-independent-of-disease-burden-as-a-risk-factor-for-survival-following-tisagenlecleucel-in-children-and-young-adults%2C-ash-2020%2C-abstract 2025-03-06 https://www.prwcc.org/jobs-1/john-molina-et-al.%2C-cytogenetics-risk-stratification-in-the-pediatric-car-setting-diverge-from-established-predictive-criteria-used-for-chemotherapy%2C-ash-2020%2C-abstract 2025-03-06 https://www.prwcc.org/jobs-1/stefanski-he%2C-eaton-a%2C-baggott-c%2C-rossoff-j%2C-verneris-mr%2C-prabhu-s%2C-pacenta-hl%2C-phillips-cl%2C-talano-ja%2C-moskop-a%2C-margossian-sp%2C-myers-gd%2C-karras-na%2C-brown-pa%2C-qayed-m%2C-hermiston-m%2C-satwani-p%2C-krupski-mc%2C-keating-ak%2C-wilcox-r%2C-rabik-ca%2C-fabrizio-va%2C-chinnabhandar-v%2C-goksenin-ay%2C-curran-kj%2C-mackall-cl%2C-laetsch-tw%2C-schultz-lm.-higher-doses-of-tisagenlecleucel-are-associated-with-improved-outcomes%3A-a-report-from-the-pediatric-real-world-car-consortium.-blood-adv.-2023-feb-28%3B7(4)%3A541-548.-doi%3A-10.1182%2Fbloodadvances.2022007246.-pmid%3A-35938863%3B-pmcid%3A-pmc9979765. 2025-03-06 https://www.prwcc.org/jobs-1/mcnerney-ko%2C-lim-ss%2C-ishikawa-k.%2C-dreyzin-a%2C-vatsayan-a%2C-chen-j%2C-baggott-c%2C-prabhu-s%2C-pacenta-hl%2C-philips-cl%2C-rossoff-j%2C-stefanski-he%2C-talano-ja%2C-moskop-a%2C-verneris-mr%2C-myers-d%2C-karras-na%2C-brown-pa%2C-bonifant-cl%2C-qayed-m%2C-hermiston-ml%2C-satwani-p%2C-krupski-c%2C-keating-ak%2C-baumeister-sh%2C-fabrizio-va%2C-chinnabdhander-v%2C-egeler-e%2C-mavroukakis-s%2C-curran-kj%2C-mackall-cl%2C-laetsch-tw%2C-schultz-l.-hlh-like-toxicities-predict-poor-survival-following-real-world-use-of-tisagenlecleucel-in-children-and-young-adults-with-b-all%2C-blood-advances-march-1%2C-2023.-https%3A%2F%2Fdoi.org%2F10.1182%2Fbloodadvances.2022008893 2025-03-06 https://www.prwcc.org/jobs-1/barsan-v%2C-li-y%2C-prabhu-s%2C-baggott-c%2C-nguyen-k%2C-pacenta-h%2C-phillips-cl%2C-rossoff-j%2C-stefanski-h%2C-talano-ja%2C-moskop-a%2C-baumeister-s%2C-verneris-mr%2C-myers-gd%2C-karras-na%2C-cooper-s%2C-qayed-m%2C-hermiston-m%2C-satwani-p%2C-krupski-c%2C-keating-a%2C-fabrizio-v%2C-chinnabhandar-v%2C-kunicki-m%2C-curran-kj%2C-mackall-cl%2C-laetsch-tw%2C-schultz-lm.-tisagenlecleucel-utilisation-and-outcomes-across-refractory%2C-first-relapse-and-multiply-relapsed-b-cell-acute-lymphoblastic-leukemia%3A-a-retrospective-analysis-of-real-world-patterns.-eclinicalmedicine.-2023-oct-26%3B65%3A102268.-doi%3A-10.1016%2Fj.eclinm.2023.102268.-pmid%3A-37954907%3B-pmcid%3A-pmc10632672. 2025-03-06 https://www.prwcc.org/jobs-1/eylon-m%2C-prabhu-s%2C-john-s%2C-king-mjm%2C-bhatt-d%2C-curran-kj%2C-erickson-c%2C-karras-na%2C-phillips-cl%2C-satwani-p%2C-hermiston-m%2C-southworth-e%2C-baumeister-shc%2C-talano-ja%2C-macmillan-ml%2C-rossoff-j%2C-bonifant-cl%2C-myers-gd%2C-rouce-rh%2C-toner-k%2C-driscoll-ta%2C-katsanis-e%2C-salzberg-db%2C-schiff-d%2C-de-oliveira-sn%2C-capitini-cm%2C-pacenta-hl%2C-pfeiffer-t%2C-shah-nc%2C-huynh-v%2C-skiles-jl%2C-fraint-e%2C-mcnerney-ko%2C-quigg-tc%2C-krueger-j%2C-ligon-ja%2C-fabrizio-va%2C-baggott-c%2C-laetsch-tw%2C-schultz-lm.-mediport-use-as-an-acceptable-standard-for-car-t-cell-infusion.-front-immunol.-2023-oct-27%3B14%3A1239132.-doi%3A-10.3389%2Ffimmu.2023.1239132.-pmid%3A-37965315%3B-pmcid%3A-pmc10642031. 2025-03-06 https://www.prwcc.org/jobs-1/christa-krupski-et-al.%2C-outcomes-following-tisagenlecleucel-reinfusion-in-children-and-young-adults-with-b-cell-acute-lymphocytic-leukemia%2C-astct-2023%2C-late-breaking-oral-abstract 2025-03-07 https://www.prwcc.org/jobs-1/rossoff-j%2C-baggott-c%2C-prabhu-s%2C-pacenta-h%2C-phillips-cl%2C-stefanski-h%2C-talano-ja%2C-moskop-a%2C-margossian-sp%2C-verneris-mr%2C-myers-gd%2C-karras-n%2C-brown-pa%2C-qayed-m%2C-hermiston-m%2C-satwani-p%2C-krupski-c%2C-keating-ak%2C-wilcox-r%2C-rabik-ca%2C-fabrizio-va%2C-kunicki-m%2C-chinnabhandar-v%2C-goksenin-ay%2C-curran-kj%2C-mackall-cl%2C-laetsch-tw%2C-schultz-lm.-out-of-specification-tisagenlecleucel-does-not-compromise-safety-or-efficacy-in-pediatric-acute-lymphoblastic-leukemia.-blood.-2021-nov-25%3B138(21)%3A2138-2142.-doi%3A-10.1182%2Fblood.2021012392.-pmid%3A-34499715%3B-pmcid%3A-pmc8617436. 2025-03-06 https://www.prwcc.org/jobs-1/fabrizio-va%2C-phillips-cl%2C-lane-a%2C-baggott-c%2C-prabhu-s%2C-egeler-e%2C-mavroukakis-s%2C-pacenta-h%2C-rossoff-j%2C-stefanski-he%2C-talano-ja%2C-moskop-a%2C-margossian-sp%2C-verneris-mr%2C-myers-gd%2C-karras-na%2C-brown-pa%2C-qayed-m%2C-hermiston-m%2C-satwani-p%2C-krupski-c%2C-keating-ak%2C-wilcox-r%2C-rabik-ca%2C-chinnabhandar-v%2C-kunicki-m%2C-goksenin-ay%2C-curran-kj%2C-mackall-cl%2C-laetsch-tw%2C-schultz-lm.-tisagenlecleucel-outcomes-in-relapsed%2Frefractory-extramedullary-all%3A-a-pediatric-real-world-car-consortium-report.-blood-adv.-2022-jan-25%3B6(2)%3A600-610.-doi%3A-10.1182%2Fbloodadvances.2021005564.-pmid%3A-34794180%3B-pmcid%3A-pmc8791593. 2025-03-06 https://www.prwcc.org/jobs-1/schultz-lm%2C-baggott-c%2C-prabhu-s%2C-pacenta-hl%2C-phillips-cl%2C-rossoff-j%2C-stefanski-he%2C-talano-ja%2C-moskop-a%2C-margossian-sp%2C-verneris-mr%2C-myers-gd%2C-karras-na%2C-brown-pa%2C-qayed-m%2C-hermiston-m%2C-satwani-p%2C-krupski-c%2C-keating-ak%2C-wilcox-r%2C-rabik-ca%2C-fabrizio-va%2C-rouce-rh%2C-chinnabhandar-v%2C-kunicki-m%2C-barsan-vv%2C-goksenin-ay%2C-li-y%2C-mavroukakis-s%2C-egeler-e%2C-curran-kj%2C-mackall-cl%2C-laetsch-tw.-disease-burden-affects-outcomes-in-pediatric-and-young-adult-b-cell-lymphoblastic-leukemia-after-commercial-tisagenlecleucel%3A-a-pediatric-real-world-chimeric-antigen-receptor-consortium-report.-j-clin-oncol.-2022-mar-20%3B40(9)%3A945-955.-doi%3A-10.1200%2Fjco.20.03585.-epub-2021-dec-9.-pmid%3A-34882493%3B-pmcid%3A-pmc9384925. 2025-03-06 https://www.prwcc.org/jobs-1/fabrizio-va%2C-boelens-jj%2C-mauguen-a%2C-baggott-c%2C-prabhu-s%2C-egeler-e%2C-mavroukakis-s%2C-pacenta-h%2C-phillips-cl%2C-rossoff-j%2C-stefanski-he%2C-talano-ja%2C-moskop-a%2C-margossian-sp%2C-verneris-mr%2C-myers-gd%2C-karras-na%2C-brown-pa%2C-qayed-m%2C-hermiston-m%2C-satwani-p%2C-krupski-c%2C-keating-ak%2C-wilcox-r%2C-rabik-ca%2C-chinnabhandar-v%2C-kunicki-m%2C-goksenin-ay%2C-mackall-cl%2C-laetsch-tw%2C-schultz-lm%2C-curran-kj.-optimal-fludarabine-lymphodepletion-is-associated-with-improved-outcomes-after-car-t-cell-therapy.-blood-adv.-2022-apr-12%3B6(7)%3A1961-1968.-doi%3A-10.1182%2Fbloodadvances.2021006418.-erratum-in%3A-blood-adv.-2023-jun-27%3B7(12)%3A2924.-pmid%3A-34788386%3B-pmcid%3A-pmc9006295. 2025-03-06 https://www.prwcc.org/jobs-1/moskop-a%2C-pommert-l%2C-baggott-c%2C-prabhu-s%2C-pacenta-hl%2C-phillips-cl%2C-rossoff-j%2C-stefanski-he%2C-talano-ja%2C-margossian-sp%2C-verneris-mr%2C-myers-gd%2C-karras-na%2C-brown-pa%2C-qayed-m%2C-hermiston-ml%2C-satwani-p%2C-krupski-c%2C-keating-ak%2C-wilcox-r%2C-rabik-ca%2C-fabrizio-va%2C-chinnabhandar-v%2C-goksenin-ay%2C-curran-kj%2C-mackall-cl%2C-laetsch-tw%2C-guest-em%2C-breese-eh%2C-schultz-lm.-real-world-use-of-tisagenlecleucel-in-infant-acute-lymphoblastic-leukemia.-blood-adv.-2022-jul-26%3B6(14)%3A4251-4255.-doi%3A-10.1182%2Fbloodadvances.2021006393.-pmid%3A-35580324%3B-pmcid%3A-pmc9327536. 2025-03-06 https://www.prwcc.org/jobs-1/schultz-lm%2C-eaton-a%2C-baggott-c%2C-rossoff-j%2C-prabhu-s%2C-keating-ak%2C-krupski-c%2C-pacenta-h%2C-philips-cl%2C-talano-ja%2C-moskop-a%2C-baumeister-shc%2C-myers-gd%2C-karras-na%2C-brown-pa%2C-qayed-m%2C-hermiston-m%2C-satwani-p%2C-wilcox-r%2C-rabik-ca%2C-fabrizio-va%2C-chinnabhandar-v%2C-kunicki-m%2C-mavroukakis-s%2C-egeler-e%2C-li-y%2C-mackall-cl%2C-curran-kj%2C-verneris-mr%2C-laetsch-tw%2C-stefanski-h.-outcomes-after-nonresponse-and-relapse-post-tisagenlecleucel-in-children%2C-adolescents%2C-and-young-adults-with-b-cell-acute-lymphoblastic-leukemia.-j-clin-oncol.-2023-jan-10%3B41(2)%3A354-363.-doi%3A-10.1200%2Fjco.22.01076.-epub-2022-sep-15.-pmid%3A-36108252%3B-pmcid%3A-pmc9839307. 2025-03-06